Logo image of UMI.BR

UMICORE (UMI.BR) Stock Fundamental Analysis

EBR:UMI - Euronext Brussels - BE0974320526 - Common Stock - Currency: EUR

12.6  +0.06 (+0.48%)

Fundamental Rating

3

Taking everything into account, UMI scores 3 out of 10 in our fundamental rating. UMI was compared to 67 industry peers in the Chemicals industry. UMI may be in some trouble as it scores bad on both profitability and health. UMI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year UMI was profitable.
In the past year UMI had a positive cash flow from operations.
UMI had positive earnings in 4 of the past 5 years.
Each year in the past 5 years UMI had a positive operating cash flow.
UMI.BR Yearly Net Income VS EBIT VS OCF VS FCFUMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

UMI's Return On Assets of -15.72% is on the low side compared to the rest of the industry. UMI is outperformed by 82.09% of its industry peers.
Looking at the Return On Equity, with a value of -76.36%, UMI is doing worse than 86.57% of the companies in the same industry.
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROIC N/A
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
UMI.BR Yearly ROA, ROE, ROICUMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Gross Margin of UMI (8.17%) is worse than 83.58% of its industry peers.
In the last couple of years the Gross Margin of UMI has grown nicely.
UMI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
UMI.BR Yearly Profit, Operating, Gross MarginsUMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

2

2. Health

2.1 Basic Checks

UMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UMI has about the same amount of shares outstanding.
Compared to 5 years ago, UMI has about the same amount of shares outstanding.
UMI has a worse debt/assets ratio than last year.
UMI.BR Yearly Shares OutstandingUMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
UMI.BR Yearly Total Debt VS Total AssetsUMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

UMI has an Altman-Z score of 1.70. This is a bad value and indicates that UMI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.70, UMI is doing worse than 70.15% of the companies in the same industry.
The Debt to FCF ratio of UMI is 12.00, which is on the high side as it means it would take UMI, 12.00 years of fcf income to pay off all of its debts.
UMI's Debt to FCF ratio of 12.00 is fine compared to the rest of the industry. UMI outperforms 61.19% of its industry peers.
A Debt/Equity ratio of 1.49 is on the high side and indicates that UMI has dependencies on debt financing.
UMI has a worse Debt to Equity ratio (1.49) than 85.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Altman-Z 1.7
ROIC/WACCN/A
WACC5.84%
UMI.BR Yearly LT Debt VS Equity VS FCFUMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

UMI has a Current Ratio of 1.28. This is a normal value and indicates that UMI is financially healthy and should not expect problems in meeting its short term obligations.
UMI has a worse Current ratio (1.28) than 76.12% of its industry peers.
A Quick Ratio of 0.77 indicates that UMI may have some problems paying its short term obligations.
The Quick ratio of UMI (0.77) is worse than 79.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.77
UMI.BR Yearly Current Assets VS Current LiabilitesUMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for UMI have decreased strongly by -43.01% in the last year.
UMI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.85% yearly.
Looking at the last year, UMI shows a very negative growth in Revenue. The Revenue has decreased by -18.68% in the last year.
The Revenue has been decreasing by -3.21% on average over the past years.
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%

3.2 Future

Based on estimates for the next years, UMI will show a small growth in Earnings Per Share. The EPS will grow by 7.13% on average per year.
UMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.83% yearly.
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y7.13%
Revenue Next Year-5.32%
Revenue Next 2Y-0.3%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UMI.BR Yearly Revenue VS EstimatesUMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
UMI.BR Yearly EPS VS EstimatesUMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.89 indicates a reasonable valuation of UMI.
Based on the Price/Earnings ratio, UMI is valued cheaply inside the industry as 88.06% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.92. UMI is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 12.32, UMI is valued correctly.
UMI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. UMI is cheaper than 73.13% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. UMI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 11.89
Fwd PE 12.32
UMI.BR Price Earnings VS Forward Price EarningsUMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

88.06% of the companies in the same industry are more expensive than UMI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.84
EV/EBITDA N/A
UMI.BR Per share dataUMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.94%
EPS Next 3Y3.83%

4

5. Dividend

5.1 Amount

UMI has a Yearly Dividend Yield of 2.79%. Purely for dividend investing, there may be better candidates out there.
UMI's Dividend Yield is a higher than the industry average which is at 3.00.
UMI's Dividend Yield is comparable with the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of UMI has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
UMI.BR Yearly Dividends per shareUMI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of UMI are negative and hence is the payout ratio. UMI will probably not be able to sustain this dividend level.
The dividend of UMI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-13%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
UMI.BR Yearly Income VS Free CF VS DividendUMI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

UMICORE

EBR:UMI (6/27/2025, 7:00:00 PM)

12.6

+0.06 (+0.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-14 2025-02-14/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners38.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.10B
Analysts54.78
Price Target11.89 (-5.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP-13%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.46%
PT rev (3m)-0.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-26.45%
Valuation
Industry RankSector Rank
PE 11.89
Fwd PE 12.32
P/S 0.21
P/FCF 10.84
P/OCF 3.57
P/B 1.6
P/tB 2
EV/EBITDA N/A
EPS(TTM)1.06
EY8.41%
EPS(NY)1.02
Fwd EY8.11%
FCF(TTM)1.16
FCFY9.23%
OCF(TTM)3.53
OCFY27.98%
SpS60.28
BVpS7.87
TBVpS6.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.17%
FCFM 1.93%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score2
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Debt/EBITDA N/A
Cap/Depr 204.16%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.77
Altman-Z 1.7
F-Score2
WACC5.84%
ROIC/WACCN/A
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y7.13%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%
Revenue Next Year-5.32%
Revenue Next 2Y-0.3%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.83%
EBIT growth 1Y-313.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.35%
EBIT Next 3Y19.67%
EBIT Next 5Y15.5%
FCF growth 1Y81.43%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-16.68%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%